Cholinergic agonism alters cognitive processing and enhances brain functional connectivity in patients with multiple sclerosis

Journal of Psychopharmacology

Volumn 23, Issue 6, 2009, Pages 686-696

  Cader, S ^a,b   Palace, J ^c   Matthews, P M ^a,d,e  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c RADCLIFFE INFIRMARY   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Acetylcholine; Cognition; FMRI; Multiple sclerosis; Neuropsychology

Indexed keywords

DOMPERIDONE; PLACEBO; RIVASTIGMINE;

ADULT; ARTICLE; ATTENTION; BRAIN FUNCTION; CINGULATE GYRUS; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DIZZINESS; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; FRONTAL LOBE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; LEARNING; LEFT HEMISPHERE; MALE; MEMORY; MULTIPLE SCLEROSIS; NAUSEA; NEUROPSYCHOLOGICAL TEST; PARIETAL LOBE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RIGHT HEMISPHERE; SINGLE BLIND PROCEDURE; TASK PERFORMANCE; VOMITING; WORD RECOGNITION;

ADULT; BRAIN; CHOLINERGIC AGONISTS; COGNITION; CROSS-OVER STUDIES; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; SINGLE-BLIND METHOD;

EID: 67651171470     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108093271     Document Type: Article

References (52)

1. Achiron A Barak Y (2003) Cognitive impairment in probable multiple sclerosis. J Neurol Neurosurg Psychiatry 74: 443-446.
2. Bagert B Camplair P Bourdette D (2002) Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management. CNS Drugs 16: 445-455.
3. Behrens TE Woolrich MW Smith S (2003) Multi-Subject Null Hypothesis Testing Using a Fully Bayesian Framework: Theory. New York: HBM.
4. Bever CT Grattan L Panitch HS Johnson KP (1995) The brief repeatable battery of neuropsychological tests for multiple sclerosis: a preliminary serial study. Mult Scler 1: 165-169.
5. Boringa JB Lazeron RH Reuling IE Ader HJ Pfennings L Lindeboom J (2001) The brief repeatable battery of neuropsychological tests: normative values allow application in multiple sclerosis clinical practice. Mult Scler 7: 263-267.
6. Braver TS Cohen JD Nystrom LE Jonides J Smith EE Noll DC (1997) A parametric study of prefrontal cortex involvement in human working memory. Neuroimage 5: 49-62.
7. Buschke H Fuld PA (1974) Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 24: 1019-1025.
8. Bush G Whalen PJ Rosen BR Jenike MA Mcinerney SC Rauch SL (1998) The counting stroop: an interference task specialized for functional neuroimaging-validation study with functional MRI. Hum Brain Mapp 6: 270-282.
9. Cader S Cifelli A Abu-Omar Y Palace J Matthews PM (2006) Reduced brain functional reserve and altered functional connectivity in patients with multiple sclerosis. Brain 129: 527-537.
10. Dacey RG Bassett JE (1987) Cholinergic vasodilation of intracerebral arterioles in rats. Am J Physiol 253: H1253 - H1260.
11. Evangelou N Esiri MM Smith S Palace J Matthews PM (2000) Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol 47: 391-395.
12. Forman SD Cohen JD Fitzgerald M Eddy WF Mintun MA Noll DC (1995) Improved assessment of significant activation in functional magnetic resonance imaging (fMRI). use of a cluster-size threshold. Magn Reson Med 33: 636-647.
13. Friston KJ Poline JP Worsley KJ Evans AC (1997) Combining spatial extent 2nd peak intensity to test for activations in functional imaging. Neuroimage 5: 83-96.
14. Furey ML Pietrini P Haxby JV (2000) Cholinergic enhancement and increased selectivity of perceptual processing during working memory. Science 290: 2315-2319.
15. Gold PE (2003) Acetylcholine modulation of neural systems involved in learning and memory. Neurobiol Learn Mem 80: 194-210.
16. Gottwald MD Rozanski RI (1999) Rivastigmine, a brain-region selective acetylcholinesterase inhibitor for treating Alzheimer's disease: review and current status. Expert Opin Investig Drugs 8: 1673-1682.
17. Greene YM Tariot PN Wishart H Cox C Holt CJ Schwid S (2000) A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments. J Clin Psychopharmacol 20: 350-356.
18. Gronwall DM (1977) Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills 44: 367-373.
19. Gu Q (2002) Neuromodulatory transmitter systems in the cortex and their role in cortical plasticity. Neuroscience 111: 815-835.
20. Jann MW (2000) Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease. Pharmacotherapy 20: 1-12.
21. Jenkinson M Smith S (2001) A global optimisation method for robust affine registration of brain images. Med Image Anal 5: 143-156.
22. Kimura F (2000) Cholinergic modulation of cortical function: a hypothetical role in shifting the dynamics in cortical network. Neurosci Res 38: 19-26.
23. Krupp LB Christodoulou C Melville P Scherl WF Macallister WS Elkins LE (2004) Donepezil improved memory in multiple sclerosis in a randomized clinical trial. Neurology 63: 1579-1585.
24. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444-1452.
25. Lavretsky EP Jarvik LF (1992) A group of potassium-channel blockers-acetylcholine releasers: new potentials for Alzheimer disease? A review. J Clin Psychopharmacol 12: 110-118.
26. Mainero C Inghilleri M Pantano P Conte A Lenzi D Frasca V (2004) Enhanced brain motor activity in patients with MS after a single dose of 3,4-diaminopyridine. Neurology 62: 2044-2050.
27. Matthews PM Honey GD Bullmore ET (2006) Applications of fMRI in translational medicine and clinical practice. Nat Rev Neurosci 7: 732-744.
28. Matthews PM Johansen-Berg H Reddy H (2004) Non-invasive mapping of brain functions and brain recovery: applying lessons from cognitive neuroscience to neurorehabilitation. Restor Neurol Neurosci 22: 245-260.
29. Mcgaughy J Everitt BJ Robbins TW Sarter M (2000) The role of cortical cholinergic afferent projections in cognition: impact of new selective immunotoxins. Behav Brain Res 115: 251-263.
30. Nelson HE (1991) National Adult Reading Test (NART). Windsor (UK): NFER-Nelson.
31. Parry AM Scott RB Palace J Smith S Matthews PM (2003) Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine. Brain 126: 2750-2760.
32. Penny WD Stephan KE Mechelli A Friston KJ (2004) Modelling functional integration: a comparison of structural equation and dynamic causal models. Neuroimage 23 (Suppl 1). S264 - S274.
33. Poser CM Paty DW Scheinberg L Mcdonald WI Davis FA Ebers GC (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13: 227-231.
34. Ramnani N Behrens TE Penny W Matthews PM (2004) New approaches for exploring anatomical and functional connectivity in the human brain. Biol Psychiatry 56: 613-619.
35. Rao CR (1973) Linear Statistical Inference and Its Applications. New York: Wiley.
36. Rao SM Leo GJ Ellington L Nauertz T Bernardin L Unverzagt F (1991) Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 41: 692-696.
37. Rosler M Anand R Cicin-Sain A Gauthier S Agid Y Dal-Bianco P (1999) Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial. Bmj 318: 633-638.
38. Sarter M Bruno JP Givens B (2003) Attentional functions of cortical cholinergic inputs: what does it mean for learning and memory. Neurobiol Learn Mem 80: 245-256.
39. Sarter M Bruno JP Turchi J (1999) Basal forebrain afferent projections modulating cortical acetylcholine, attention, and implications for neuropsychiatric disorders. Ann N Y Acad Sci 877: 368-382.
40. Sato A Sato Y Uchida S (2004) Activation of the intracerebral cholinergic nerve fibers originating in the basal forebrain increases regional cerebral blood flow in the rat's cortex and hippocampus. Neurosci Lett 361: 90-93.
41. Sato H Hata Y Masui H Tsumoto T (1987) A functional role of cholinergic innervation to neurons in the cat visual cortex. J Neurophysiol 58: 765-780. (Pubitemid 18006795)
42. Smith A (1982) The Symbol Digit Modalities Test Manual, Revised. Los Angeles: Western Psychological services.
43. Smith KJ Hall SM (2001) Factors directly affecting impulse transmission in inflammatory demyelinating disease: recent advances in our understanding. Curr Opin Neurol 14: 289-298.
44. Steinacker A Rojas L (1988) Acetylcholine modulated potassium channel in the hair cell of the toadfish saccule. Hear Res 35: 265-269.
45. Turchi J Sarter M (1997) Cortical acetylcholine and processing capacity: effects of cortical cholinergic deafferentation on crossmodal divided attention in rats. Brain Res Cogn Brain Res 6: 147-158.
46. Uzum G Diler AS Bahcekapili N Tasyurekli M Ziylan YZ (2004) Nicotine improves learning and memory in rats: morphological evidence for acetylcholine involvement. Int J Neurosci 114: 1163-1179.
47. Wang H Sun X (2005) Desensitized nicotinic receptors in brain. Brain Res Brain Res Rev 48: 420-437.
48. Wegner C Esiri MM Chance SA Palace J Matthews PM (2006) Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 67: 960-967.
49. Wesnes KA Mckeith IG Ferrara R Emre M Del Ser T Spano PF (2002) Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system. Dement Geriatr Cogn Disord 13: 183-192.
50. Woolrich MW Ripley BD Brady M Smith SM (2001) Temporal autocorrelation in univariate linear modeling of FMRI data. Neuroimage 14: 1370-1386.
51. Worsley KJ Evans AC Marrett S Neelin P (1992) A three-dimensional statistical analysis for CBF activation studies in human brain. J Cereb Blood Flow Metab 12: 900-918.
52. Zigmond AS Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67: 361-370.